High impact EMBO Molecular Medicine to Publish Under Open Access Model

EMBO Molecular Medicine, as of March 2012, joins the Wiley Open Access publishing program. Articles in the journal are open access and free to view, download and share for non-commercial use.

EMBO Molecular Medicine is one of the highest profile biomedical journals to have converted to the open access model.  Since its launch in 2009, EMBO Molecular Medicine has attracted extremely high quality submissions and attained a first Impact Factor of 8.833, placing it 6th in the Medicine Research and Experimental ISI Category. With its emphasis on translational medicine, the studies published in EMBO Molecular Medicine are of interest to a wide spectrum of researchers, clinicians and the public. Converting to open access allows all readers to benefit from the high-level research advances reported in EMBO Molecular Medicine, aiding the dissemination of biomedical research and accelerating discovery.